Plain-English translation of NCT06658197 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
When someone has a major stroke caused by a blood clot in the brain, doctors need to act fast. This trial is testing whether , a newer clot-busting medication, works as well as or better than , the standard drug used today. Both groups will also receive emergency surgery to physically remove the clot from the brain.
Doctors want to know if the newer medication can help more stroke patients recover better and with fewer complications when combined with emergency clot removal surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify and join this trial, you will be randomly assigned to receive one of two clot-busting medications through an IV before undergoing emergency surgery to remove the blood clot from your brain. After treatment, you will have follow-up visits and assessments over 90 days to check your recovery and how well the treatment worked. The research team will evaluate your ability to function independently and look for any side effects.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China